Availability of Poor Quality Embryos

The purpose of this study is to explore a method to identify the viability of day-3 poor quality embryos

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infertility Genital Diseases Urogenital Diseases

Age range

20 year–40 year

Sex eligibility

Female

Study type

Observational

Primary location

The Second Affiliated Hospital of Kunming Medical University

Kunming, Yunnan, 650101, China

About this study

Day-3 poor quality embryos are related to significant lower clinical pregnancy,so freezing numerous poor quality embryos are clinical impractical. To ensure the successful pregnancy and to enhance the availability of the poor quality embryos, day-3 poor quality embryos are further cultured to different developmental stage and then cryopreserved. The viability of these embryos are tested in frozen-thawed transfer.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

unfertile women

Exclusion criteria

women older than 40 years

Treatment and study plan

Primary outcomes

pregnancy rate

Time frame: 5 weeks

Sponsors and collaborators

Lead sponsor

The Second Affiliated Hospital of Kunming Medical University

Other

Registry information

Official study title

Availability of Poor Quality Embryos in Frozen-thawed Embryo Transfer Cycles

Acronym: Availability

Important dates

Study start: 2011
Primary completion: 2012
Study completion: 2012
First posted: Oct 29, 2012
Registry last updated: Oct 29, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed